Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» After failed trials, J&J pivots to early-stage Alzheimer's
After failed trials, J&J pivots to early-stage Alzheimer's
After failed trials, J&J pivots to early-stage Alzheimer's
Submitted by
admin
on February 13, 2013 - 10:44am
Source:
Reuters
News Tags:
Alzheimer's disease
JNJ
bapineuzumab
Headline:
After failed trials, J&J pivots to early-stage Alzheimer's
Do Not Allow Advertisers to Use My Personal information
